Results 71 to 80 of about 61,573 (234)

Antimicrobial Resistance in Children With Bloodstream Infections: A Population‐Based Study in Stockholm, Sweden

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim We retrospectively evaluated trends in antimicrobial resistance (AMR) in paediatric bloodstream infections and assessed changes in antimicrobial prescription patterns over a 20‐year period. Methods We analysed positive blood cultures from children admitted with suspected serious infection between 1998 and 2018.
Joachim Luthander   +5 more
wiley   +1 more source

Severe Myelosuppression Induced by Piperacillin/Tazobactam: A Case Report [PDF]

open access: yes
This case report presents an elderly patient who developed severe bone marrow suppression following the administration of Piperacillin/Tazobactam.
Huang, Aiyun, Tian, Liya
core   +1 more source

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States

open access: yesAntimicrobial Resistance and Infection Control, 2017
Background The prevalence of antimicrobial resistance among gram-negative pathogens in complicated intra-abdominal infections (cIAIs) has increased. In the absence of timely information on the infecting pathogens and their susceptibilities, local or ...
Vimalanand S. Prabhu   +8 more
doaj   +1 more source

Tigecycline combination therapy for fulminant Clostridioides difficile infection: an Australian experience

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop   +5 more
wiley   +1 more source

Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis

open access: yes, 2012
Piperacillin/tazobactam is a commonly prescribed antibiotic and is generally considered safe. We report a case of a 2-year-old girl who developed hypokalemic metabolic alkalosis and bradycardia after receiving intravenous piperacillin-tazobactam for ...
Lad, Vijay, Zaki, Syed Ahmed.
core   +1 more source

Adverse Event Signals Associated with Beta-Lactamase Inhibitors: Disproportionality Analysis of USFDA Adverse Event Reporting System

open access: yesJournal of Xenobiotics
Background: Beta-lactamase inhibitors (BLIs) are widely used with beta-lactam antibiotics to combat resistant infections, yet their safety profiles, especially for newer agents, remain underexplored.
Kannan Sridharan, Gowri Sivaramakrishnan
doaj   +1 more source

Topical piperacillin/tazobactam for recalcitrant pseudomonas aeruginosa keratitiS

open access: yes, 2010
Purpose: To report the treatment of therapy-resistant Pseudomonas aeruginosa keratitis with topical piperacillin/tazobactam. Methods: Retrospective report of 3 cases. Results: Three patients with P.
Shin, H.C.   +4 more
core   +2 more sources

Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis

open access: yes, 2019
Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous adverse reaction mainly attributed to antibiotics. It is characterized by numerous, nonfollicular, sterile pustules, arising on an exanthematous and edematous base.
Sofia-Chrysovalantou Zagalioti   +4 more
core   +1 more source

The addition of clotrimazole reduces but does not abrogate fungal dysbiosis during effective antibacterial therapy for canine otitis externa

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives Malassezia dysbiosis commonly occurs after successful piperacillin‐tazobactam monotherapy for canine bacterial otitis externa. The study objective was to compare antimicrobial outcomes in dogs with otitis treated with piperacillin‐tazobactam in combination with the antifungal drug clotrimazole with a previous cohort treated with piperacillin‐
G. Gallow   +8 more
wiley   +1 more source

Population Pharmacokinetic Modeling of Piperacillin/Tazobactam in Healthy Adults and Exploration of Optimal Dosing Strategies

open access: yesPharmaceuticals
Background/Objectives: Current dosing recommendations for piperacillin/tazobactam suggest adjustments only for patients with creatinine clearance (CrCl) below 40 mL/min, potentially neglecting the variability in drug exposure among patients with a CrCl ...
Yun Jung Lee   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy